Singapore markets closed
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,071.63 +1.08 (+0.02%) Dow
38,460.92 -42.77 (-0.11%) Nasdaq
15,712.75 +16.11 (+0.10%) Bitcoin USD
63,927.41 -2,461.06 (-3.71%) CMC Crypto 200
1,360.92 -21.65 (-1.57%)
Medexus Pharmaceuticals Inc. (MEDXF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:13PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 31.15M |
| Enterprise value | 75.22M |
| Trailing P/E | 4.48 |
| Forward P/E | 7.24 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.24 |
| Price/book (mrq) | 1.08 |
| Enterprise value/revenue | 0.65 |
| Enterprise value/EBITDA | 3.81 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.85 |
| 52-week change 3 | 28.71% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 2.5620 |
| 52-week low 3 | 0.8380 |
| 50-day moving average 3 | 1.2170 |
| 200-day moving average 3 | 1.6419 |
Share statistics
| Avg vol (3-month) 3 | 18.58k |
| Avg vol (10-day) 3 | 19.92k |
| Shares outstanding 5 | 24.46M |
| Implied shares outstanding 6 | 24.65M |
| Float 8 | 20.59M |
| % held by insiders 1 | 8.69% |
| % held by institutions 1 | 11.35% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 19 Dec 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 5.08% |
| Operating margin (ttm) | 6.22% |
Management effectiveness
| Return on assets (ttm) | 5.21% |
| Return on equity (ttm) | 26.14% |
Income statement
| Revenue (ttm) | 115.72M |
| Revenue per share (ttm) | 5.46 |
| Quarterly revenue growth (yoy) | -12.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 18.32M |
| Net income avi to common (ttm) | 5.88M |
| Diluted EPS (ttm) | 0.2900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 8.21M |
| Total cash per share (mrq) | 0.34 |
| Total debt (mrq) | 52.29M |
| Total debt/equity (mrq) | 176.88% |
| Current ratio (mrq) | 1.11 |
| Book value per share (mrq) | 1.21 |
Cash flow statement
| Operating cash flow (ttm) | 20.97M |
| Levered free cash flow (ttm) | 8.24M |
© 2024 Yahoo. All rights reserved.